µÏÍþ¹ú¼Ê

    • µÏÍþÖƵÏÍþ¹ú¼Ê µÏÍþÖƵÏÍþ¹ú¼Ê

    ¼ò ¤™
    • ¼ò
    • ·±
    • EN
    ¤œ
    Ïà¹ØÁ´½Ó
    • ½­ËÕºÀÉ­µÏÍþ¹ú¼ÊÒµ¼¯ÍÅÓÐÏÞ¹«Ë¾¥Y
    ÐÂÎÅ·¢²¼
    Press Release
    Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅ·¢²¼
    µÏÍþÖƵÏÍþ¹ú¼ÊHS-10529»ñÅúÁÙ´²£¬ÄâÖÎÁÆKRAS G12DÍ»±äÍíÆÚʵÌåÁö
    ·¢²¼ÈÕÆÚ£º2025/04/16
    ×ÖºÅ

    2025Äê4ÔÂ15ÈÕ£¬µÏÍþÖƵÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°µÏÍþÖƵÏÍþ¹ú¼Ê¡±£¬03692.HK£©Ðû²¼£¬¹«Ë¾×ÔÖ÷Ñз¢µÄ1ÀàеÏÍþ¹ú¼ÊHS-10529Ƭ»ñ¹ú¼ÒµÏÍþ¹ú¼ÊÆ·¼à¶½¹ÜÀí¾Ö(NMPA)Ç©·¢µÄµÏÍþ¹ú¼ÊÎïÁÙ´²ÊÔÑéÅú׼֪ͨÊ飬Ä⿪·¢ÖÎÁÆKRAS G12DÍ»±äµÄÍíÆÚʵÌåÁö¡£


    KRASÊÇÖ×ÁöÖÐÍ»±ä×îΪ¹ã·ºµÄ°©»ùÒòÖ®Ò»£¬´óÔ¼30%µÄÖ×ÁöÖж¼´æÔÚKRASÍ»±ä¡£KRASÍ»±ä°üÀ¨¶à¸ö²»Í¬µÄλµãÍ»±ä£¬ÆäÖÐ×î³£¼ûµÄÊÇG12C¡¢G12DµÈ[1]¡£Ä¿Ç°È«ÇòÉÐÎÞKRAS G12DÒÖÖƼÁ»ñÅúÉÏÊС£

    HS-10529ÊǵÏÍþÖƵÏÍþ¹ú¼Ê×ÔÖ÷Ñз¢µÄÒ»ÖÖ°ÐÏòKRAS G12DµÄС·Ö×ÓÒÖÖƼÁ£¬¾ßÓи߶ÈÑ¡ÔñÐÔ¡£ÁÙ´²Ç°µÏÍþ¹ú¼ÊЧÊÔÑé±íÃ÷£¬HS-10529¾ßÓÐÁ¼ºÃµÄÁÙ´²Ç°µÏÍþ¹ú¼ÊЧ»îÐÔ¡¢µÏÍþ¹ú¼Ê´ú¶¯Á¦Ñ§ÌØÕ÷ºÍ°²È«ÐÔ¡£

    HS-10529£¨KRAS G12DÒÖÖƼÁ£©»ñÅúÁÙ´²½øÒ»²½¼ÓÇ¿Á˵ÏÍþÖƵÏÍþ¹ú¼ÊÔÚKRASÍ»±äÖÎÁÆÁìÓòµÄ²¼¾Ö¡£2024Ä꣬¹«Ë¾HS-10370£¨KRAS G12CÒÖÖƼÁ£©ÔÚÍíÆÚʵÌåÁöÖеÄÁÙ´²Ñо¿½á¹ûÒÑÓÚÃÀ¹ú°©Ö¢Ñо¿Ð­»á£¨AACR£©Äê»áÁÁÏà¡£

    µÏÍþÖƵÏÍþ¹ú¼Ê½«Ê¼ÖÕ¼á³Ö¿Æѧ¼¼ÊõÒýÁ죬³ÖÐøÁ¢×ãδÂú×ãµÄÁÙ´²ÐèÇ󣬲»¶ÏÍØÕ¹´´Ð²úÆ·µÄÖÎÁÆDZÁ¦£¬ÎªÖйú¼°È«Çò»¼Õß´øÀ´¸ü¶à¸ßÖÊÁ¿¡¢¿É¸ºµ£µÄ´´ÐÂÖÎÁÆ·½°¸¡£


    ¹ØÓÚµÏÍþÖƵÏÍþ¹ú¼Ê

    µÏÍþÖƵÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖƵÏÍþ¹ú¼ÊÆóÒµ£¬ÒÔ¡¸³ÖÐø´´Ð£¬Ìá¸ßÈËÀàÉúÃüÖÊÁ¿¡¹ÎªÊ¹Ãü£¬Öصã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò¡£½ØÖÁÄ¿Ç°£¬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬ÐγÉÁ˷ḻµÄ²úÆ·¹ÜÏß¡£µÏÍþÖƵÏÍþ¹ú¼ÊÁ¬Ðø¶àÄêλ¾ÓÈ«ÇòÖƵÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖصã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£µÏÍþÖƵÏÍþ¹ú¼ÊÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£

    ¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£

    ²Î¿¼ÎÄÏ×£º

    [1]Punekar Salman R, Velcheti Vamsidhar, Neel Benjamin G, et al. The current state of the art and future trends in RAS-targeted cancer therapies. Nat Rev Clin Oncol, 2022, 19: 637-655.

    ÉùÃ÷£º
    1¡¢±¾¹«¸æ½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿²ÎÔÄ£¬·Ç¹ã¸æÓÃ;¡£

    2¡¢µÏÍþÖƵÏÍþ¹ú¼Ê²»ÍƼöÈκÎδ»ñÅúµÏÍþ¹ú¼ÊƷʹÓúÍ/»òδ»ñÅúÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê£¬Ò಻¶ÔÈκεÏÍþ¹ú¼ÊÆ·ºÍ/»òÊÊÓ¦Ö¢×÷ÍƼö¡£

    3¡¢±¾¹«¸æÖÐÉæ¼°µÄÐÅÏ¢½ö¹©²Î¿¼£¬Çë×ñ´ÓÒ½Éú»òÆäËûÒ½ÁÆÎÀÉúרҵÈËÊ¿µÄÒâ¼û»òÖ¸µ¼¡£Ò½ÁÆÎÀÉúרҵÈËÊ¿×÷³öµÄÈκÎÓëÖÎÁÆÓйصľö¶¨Ó¦¸ù¾Ý»¼ÕߵľßÌåÇé¿ö²¢×ñÕÕµÏÍþ¹ú¼ÊƷ˵Ã÷Êé¡£

    4¡¢ÈçÐèÁ˽⹫˾ÈκβúÆ·¡¢Ò½ÁÆ»ò¼²²¡µÄÏà¹ØÐÅÏ¢£¬ÇëÎñ±Ø×ÉѯҽÁÆÎÀÉúרҵÈËÊ¿¡£



    Ç°Õ°ÐÔ˵Ã÷


    ±¾ÐÂΟåÖ¼ÔÚÌṩ¹ØÓÚµÏÍþÖƵÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¼°Æ丽Êô¹«Ë¾£¨°üÀ¨Æä×Ó¹«Ë¾£¬Í³³ÆΪ¡°µÏÍþÖƵÏÍþ¹ú¼Ê¡±£©µÄÐÅÏ¢¡£Ëü²»¹¹³É¶ÔµÏÍþÖƵÏÍþ¹ú¼Ê»òÈκÎͶ×ʽ¨ÒéµÄÐÅÏ¢Åû¶¡£

    ±¾ÐÂΟå°üº¬µÄÐÅÏ¢¿ÉÄÜ°üÀ¨ÓëµÏÍþÖƵÏÍþ¹ú¼ÊÒµÎñºÍ²úÆ·Ç°¾°¡¢¼Æ»®¡¢ÐÅÄî¡¢Ô¤ÆںͲßÂÔÏà¹ØµÄÇ°Õ°ÐÔÉùÃ÷¡£ÕâЩÉùÃ÷ÊÇ»ùÓÚÍƲâÐÔ¼ÙÉèµÄÔ¤²â£¬²¢²»±£Ö¤Î´À´µÄ±íÏÖ¡£ËüÃÇÊܵ½ÖîÈç¿Æѧ¡¢ÉÌÒµ¡¢ÕþÖΡ¢¾­¼Ã¡¢²ÆÎñ¡¢·¨ÂÉÒòËØÒÔ¼°¾ºÕù»·¾³ºÍÉç»áÌõ¼þµÈ·çÏպͲ»È·¶¨ÐÔµÄÓ°Ï죬ÕâЩÒòËغܶ඼ÊǵÏÍþÖƵÏÍþ¹ú¼ÊÎÞ·¨¿ØÖÆÇÒÄÑÒÔÔ¤²âµÄ£¬Òò´Ëʵ¼Ê½á¹û¿ÉÄÜÓë´Ë´¦ËùÊöÓÐÏÔÖø²îÒ죬ÇÒ¹ýÈ¥µÄ֤ȯ¼Û¸ñÇ÷ÊƲ»Ó¦×÷ΪδÀ´ÐÐÇéµÄÖ¸µ¼¡£Òò´Ë£¬Í¶×ÊÕßÔÚʹÓÃÕâЩÐÅÏ¢½øÐÐͶ×ʾö²ßʱӦ½÷É÷ÐÐÊ¡£¡°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°Òâͼ¡±¡°Ô¤¼Æ¡±¡°¿ÉÄÜ¡±¡°½«¡±¡°Ó¦¸Ã¡±¡°¼Æ»®¡±¡°¼ÌÐø¡±¡°Ä¿±ê¡±¡°¿¼ÂÇ¡±¡°¹À¼Æ¡±¡°Ö¸µ¼¡±¡°Ç±ÔÚ¡±¡°×·Çó¡±ÒÔ¼°ÓÚÈκÎδÀ´¼Æ»®¡¢Ðж¯»òʼþµÄÌÖÂÛÖÐʹÓõÄÀàËÆ´ÊÓïºÍÊõÓ¾ù±íʾǰհÐÔÉùÃ÷¡£

    µÏÍþÖƵÏÍþ¹ú¼Ê²»³Ðŵ»ò±£Ö¤Ç°Õ°ÐÔÐÅÏ¢µÄ׼ȷÐÔ¡¢¼°Ê±ÐÔ»òÍêÕûÐÔ£¬²¢ÇÒ²»³Ðµ£¸üлòÐÞ¶©ÕâЩǰհÐÔÉùÃ÷µÄÒåÎñ¡£ÎÞÂÛÊǵÏÍþÖƵÏÍþ¹ú¼Ê»¹ÊÇÆäÈκζ­Ê¡¢Ô±¹¤»ò´úÀíÈË£¬¾ù²»¶ÔÈκÎÖ¤Ã÷²»×¼È·»òÎÞ·¨ÊµÏÖµÄÇ°Õ°ÐÔÉùÃ÷¸ºÔð£¬Ò²²»¶ÔÒòÒÀÀµ±¾ÐÂΟåÖÐÌṩµÄÐÅÏ¢¶ø²úÉúµÄÈκÎËðʧ»òË𺦸ºÔ𣬰üÀ¨µ«²»ÏÞÓÚÖ±½Ó¡¢Å¼È»¡¢¼ä½Ó»ò³Í·£ÐÔµÄË𺦡£

    ¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿